Cargando…

Successful mesenchymal stem cell treatment of leg ulcers complicated by Behcet disease: A case report and literature review

RATIONALE: Behçet disease (BD) is a recurrent vasculitis characterized by oral and genital mucous membrane ulcers, uveitis, and skin lesions but only rarely leg ulcers. To our knowledge, no efficacious therapy has been described for BD patients with complicating, destructive leg ulcers. PATIENT CONC...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yanhong, Wang, Zhongming, Zhao, Yi, Luo, Yubin, Xu, Wangdong, Marion, Tony N., Liu, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916712/
https://www.ncbi.nlm.nih.gov/pubmed/29668637
http://dx.doi.org/10.1097/MD.0000000000010515
_version_ 1783317066412982272
author Li, Yanhong
Wang, Zhongming
Zhao, Yi
Luo, Yubin
Xu, Wangdong
Marion, Tony N.
Liu, Yi
author_facet Li, Yanhong
Wang, Zhongming
Zhao, Yi
Luo, Yubin
Xu, Wangdong
Marion, Tony N.
Liu, Yi
author_sort Li, Yanhong
collection PubMed
description RATIONALE: Behçet disease (BD) is a recurrent vasculitis characterized by oral and genital mucous membrane ulcers, uveitis, and skin lesions but only rarely leg ulcers. To our knowledge, no efficacious therapy has been described for BD patients with complicating, destructive leg ulcers. PATIENT CONCERNS: Here, We report the case of a 55-year-old woman with generalized erythema nodosum-like, papulopustular lesions, recurrent oral and genital ulcers accompanied with recurrent leg ulcers and trouble walking. DIAGNOSES: Based upon the patient's clinical feature and positive pathergy test , BD was confirmed. INTERVENTIONS: Conventional immunosuppressive therapy and anti-tumor necrosis factor inhibitors, adalimumab and etanercept, had no demonstrable clinical effect. Mesenchymal stem cell (MSC) injection combined with low-dose prednisone and thalidomide, however, completely ameliorated the ulcers on one leg, significantly improved ulcers on the other leg, and returned normal function to both legs. OUTCOMES: The ulcerative lesions remained in remission, and the affected leg functioned normally after 34 months’ follow-up. LESSONS: Our experience suggests that MSC infusion might be a potentially successful therapy for intractable drug-resistant BD patients with concomitant leg ulcer.
format Online
Article
Text
id pubmed-5916712
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-59167122018-05-01 Successful mesenchymal stem cell treatment of leg ulcers complicated by Behcet disease: A case report and literature review Li, Yanhong Wang, Zhongming Zhao, Yi Luo, Yubin Xu, Wangdong Marion, Tony N. Liu, Yi Medicine (Baltimore) 6900 RATIONALE: Behçet disease (BD) is a recurrent vasculitis characterized by oral and genital mucous membrane ulcers, uveitis, and skin lesions but only rarely leg ulcers. To our knowledge, no efficacious therapy has been described for BD patients with complicating, destructive leg ulcers. PATIENT CONCERNS: Here, We report the case of a 55-year-old woman with generalized erythema nodosum-like, papulopustular lesions, recurrent oral and genital ulcers accompanied with recurrent leg ulcers and trouble walking. DIAGNOSES: Based upon the patient's clinical feature and positive pathergy test , BD was confirmed. INTERVENTIONS: Conventional immunosuppressive therapy and anti-tumor necrosis factor inhibitors, adalimumab and etanercept, had no demonstrable clinical effect. Mesenchymal stem cell (MSC) injection combined with low-dose prednisone and thalidomide, however, completely ameliorated the ulcers on one leg, significantly improved ulcers on the other leg, and returned normal function to both legs. OUTCOMES: The ulcerative lesions remained in remission, and the affected leg functioned normally after 34 months’ follow-up. LESSONS: Our experience suggests that MSC infusion might be a potentially successful therapy for intractable drug-resistant BD patients with concomitant leg ulcer. Wolters Kluwer Health 2018-04-20 /pmc/articles/PMC5916712/ /pubmed/29668637 http://dx.doi.org/10.1097/MD.0000000000010515 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 6900
Li, Yanhong
Wang, Zhongming
Zhao, Yi
Luo, Yubin
Xu, Wangdong
Marion, Tony N.
Liu, Yi
Successful mesenchymal stem cell treatment of leg ulcers complicated by Behcet disease: A case report and literature review
title Successful mesenchymal stem cell treatment of leg ulcers complicated by Behcet disease: A case report and literature review
title_full Successful mesenchymal stem cell treatment of leg ulcers complicated by Behcet disease: A case report and literature review
title_fullStr Successful mesenchymal stem cell treatment of leg ulcers complicated by Behcet disease: A case report and literature review
title_full_unstemmed Successful mesenchymal stem cell treatment of leg ulcers complicated by Behcet disease: A case report and literature review
title_short Successful mesenchymal stem cell treatment of leg ulcers complicated by Behcet disease: A case report and literature review
title_sort successful mesenchymal stem cell treatment of leg ulcers complicated by behcet disease: a case report and literature review
topic 6900
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916712/
https://www.ncbi.nlm.nih.gov/pubmed/29668637
http://dx.doi.org/10.1097/MD.0000000000010515
work_keys_str_mv AT liyanhong successfulmesenchymalstemcelltreatmentoflegulcerscomplicatedbybehcetdiseaseacasereportandliteraturereview
AT wangzhongming successfulmesenchymalstemcelltreatmentoflegulcerscomplicatedbybehcetdiseaseacasereportandliteraturereview
AT zhaoyi successfulmesenchymalstemcelltreatmentoflegulcerscomplicatedbybehcetdiseaseacasereportandliteraturereview
AT luoyubin successfulmesenchymalstemcelltreatmentoflegulcerscomplicatedbybehcetdiseaseacasereportandliteraturereview
AT xuwangdong successfulmesenchymalstemcelltreatmentoflegulcerscomplicatedbybehcetdiseaseacasereportandliteraturereview
AT mariontonyn successfulmesenchymalstemcelltreatmentoflegulcerscomplicatedbybehcetdiseaseacasereportandliteraturereview
AT liuyi successfulmesenchymalstemcelltreatmentoflegulcerscomplicatedbybehcetdiseaseacasereportandliteraturereview